BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioVendor - Laboratorni Medicina as - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011847
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVendor – Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company’s products include immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immuno-histochemistry, cell-based assays and colorimetric assays. Its products are used in animal studies, apoptosis, asthma and allergic rhinitis, atherosclerosis, autoimmunity, blood pressure regulation and no metabolism, bone and cartilage metabolism, cardiovascular disease, cell adhesion proteins and other research applications. The company sells its products through a network of distributors in Andorra, Belgium, Cyprus, Denmark, Finland, France, Greece, Greenland, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, the Czech Republic and the UK, among others. BioVendor is headquartered in Brno, the Czech Republic.

BioVendor – Laboratorni Medicina as – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioVendor – Laboratorni Medicina as, Medical Devices Deals, 2011 to YTD 2017 9
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
Licensing Agreements 12
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Acquisition 13
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
BioVendor – Laboratorni Medicina as – Key Competitors 14
BioVendor – Laboratorni Medicina as – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Key Facts 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVendor - Laboratorni Medicina as, Deals By Therapy Area, 2011 to YTD 2017 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2011 to YTD 2017 9
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
BioVendor - Laboratorni Medicina as, Key Competitors 14
BioVendor - Laboratorni Medicina as, Subsidiaries 15

★海外企業調査レポート[BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alpine Immune Sciences Inc (NVLS):企業の財務・戦略的SWOT分析
    Summary Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company that discovering and developing innovative, protein-based immunotherapies, immune synapse to treat cancer and autoimmune and inflammatory diseases. The has two products in the clinic for infla …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • HSBC Trinkaus & Burkhardt AG (TUB):企業の財務・戦略的SWOT分析
    HSBC Trinkaus & Burkhardt AG (TUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • International CSRC Investment Holdings Co Ltd (2104):企業の財務・戦略的SWOT分析
    International CSRC Investment Holdings Co Ltd (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Caesars Entertainment Corporation:企業の戦略・SWOT・財務情報
    Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report Summary Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Armour Residential REIT, Inc.:企業のM&A・事業提携・投資動向
    Armour Residential REIT, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Armour Residential REIT, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • ResApp Health Ltd (RAP):医療機器:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Wynn Macau Ltd:企業の戦略・SWOT・財務情報
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Crown Castle International Corp.:企業の戦略・SWOT・財務情報
    Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report Summary Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cardinal Health, Inc.:企業の戦略・SWOT・財務情報
    Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cardinal Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Halfords Group plc (HFD):企業の財務・戦略的SWOT分析
    Halfords Group plc (HFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ICA Gruppen AB:企業のM&A・事業提携・投資動向
    ICA Gruppen AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICA Gruppen AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆